Auriga reiterates a 'Buy' on United Therapeutics (Nasdaq: UTHR), raises price target from $83 to $108.

"Our checks with experts ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE